Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.32 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.32 |
| ▸ | GRM8 | O00222 | 1/20 | 0.32 |
| ▸ | GRM6 | O15303 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.32 |
| ▸ | GSR | P00390 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.32 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.32 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30338047 | 0.89 | SLC22A6 (0.38) | GABRR1SLC22A6LMNAGRIK1SLC1A1 | |
| Phenol SCHEMBL29145997 | 0.85 | SLC7A5 (0.41) | SLC7A5LMNATDP1SMN1; SMN2 | |
| SCHEMBL14742382 | 0.83 | TSHR (0.35) | SLC7A5TSHR | |
| SCHEMBL3337079 | 0.83 | TSHR (0.35) | SLC7A5TSHR | |
| SCHEMBL1075213 | 0.81 | HCAR2 (0.39) | LMNAGRIK1SLC1A1GRIK2SLC1A3 | |
| SCHEMBL1075212 | 0.81 | HCAR2 (0.39) | LMNAGRIK1SLC1A1GRIK2SLC1A3 | |
| SCHEMBL25491154 | 0.79 | SLC22A6 (0.38) | GABRR1SLC22A6LMNAGRIK1SLC1A1 | |
| SCHEMBL28051778 | 0.79 | TSHR (0.39) | SLC7A5TSHRSLC1A1 | |
| SCHEMBL5424018 | 0.79 | GRM8 (0.54) | TSHRLMNAGRIK1SLC1A1GRIK2 | |
| SCHEMBL28351827 | 0.79 | GSR (0.48) | SLC7A5GRIK1SLC1A1GRIK2GRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111135145-A | Preparation process of polyethylene glycol micelle with high drug loading | 福建齐衡科技有限公司 | 2020-05-12 | — | — | CN | claimed |
| US-20050180917-A1 | Delivery of neutron capture elements for neutron capture therapy | PSIMEI PHARMACEUTICALS PLC (GB) | 2005-08-18 | — | — | US | claimed |
| EP-1471939-A1 | DELIVERY OF NEUTRON CAPTURE ELEMENTS FOR NEUTRON CAPTURE THERAPY | Psimei Pharmaceuticals Plc (GB) | 2004-11-03 | — | — | EP | claimed |
| WO-2003055520-A1 | DELIVERY OF NEUTRON CAPTURE ELEMENTS FOR NEUTRON CAPTURE THERAPY | PSIMEI PHARMACEUTICALS PLC (GB) | 2003-07-10 | — | — | WO | claimed |
| EP-1309369-A1 | ELECTRO-POWDER | Microdrug AG (CH) | 2003-05-14 | — | — | EP | claimed |
| WO-2002011803-A1 | ELECTRO-POWDER | MICRODRUG AG (CH) | 2002-02-14 | — | — | WO | claimed |
| CN-111135145-A | Preparation process of polyethylene glycol micelle with high drug loading | 福建齐衡科技有限公司 | 2020-05-12 | — | — | CN | disclosed |
| CN-111135145-A | Preparation process of polyethylene glycol micelle with high drug loading | 福建齐衡科技有限公司 | 2020-05-12 | — | — | CN | disclosed |
| EP-1773324-B1 | PORPHYRIN DERIVATIVES AND THEIR USE IN PHOTON ACTIVATION THERAPY | PSIMEI PHARMCEUTICALS LTD (GB) | 2015-04-01 | — | — | EP | disclosed |
| US-7816518-B2 | Porphyrin derivatives and their use in photon activation therapy | PSIMEI PHARMACEUTICALS, PLC (GB) | 2010-10-19 | — | — | US | disclosed |
| US-20080039436-A1 | Porphyrin Derivatives And Their Use In Photon Activation Therapy | PSIMEI PHARMACEUTICALS, PLC (GB) | 2008-02-14 | — | — | US | disclosed |
| US-7273845-B2 | Polymeric prodrugs of vancomycin | ENZON PHARMACEUTICALS, INC. (US) | 2007-09-25 | — | — | US | disclosed |
| EP-1773324-A1 | PORPHYRIN DERIVATIVES AND THEIR USE IN PHOTON ACTIVATION THERAPY | Psimei Pharmaceuticals Plc (GB) | 2007-04-18 | — | — | EP | disclosed |
| US-20050031575-A1 | Block copolymers | POLYTHERICS LIMITIED (GB) | 2005-02-10 | — | — | US | disclosed |
| US-20040136947-A1 | vancomycin-polymer conjugate; polymer is attached to both of the vancomycin amino groups | BELROSE PHARMA INC. | 2004-07-15 | — | — | US | disclosed |
| WO-2004044224-A2 | BRANCHED POLYMERIC PRODRUGS OF VANCOMYCIN | ENZON PHARMACEUTICALS, INC. (US) | 2004-05-27 | — | — | WO | disclosed |
| WO-2004044222-A2 | POLYMERIC PRODRUGS OF VANCOMYCIN | ENZON PHARMACEUTICALS, INC. (US) | 2004-05-27 | — | — | WO | disclosed |
| US-6696090-B1 | MICRONIZED MEDICAL POWDER ELECTROSTATICALLY CHARGED BY CORONA, INDUCTION, OR TRIBOELECTRICITY; LUNG AIRWAY OR ORAL INHALATION ADMINISTRATION OF ANTIASTHMATIC AGENT | MICRODRUG AG (CH) | 2004-02-24 | — | — | US | disclosed |
| EP-1309369-A1 | ELECTRO-POWDER | Microdrug AG (CH) | 2003-05-14 | — | — | EP | disclosed |
| WO-2002011803-A1 | ELECTRO-POWDER | MICRODRUG AG (CH) | 2002-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040136947-A1 | vancomycin-polymer conjugate; polymer is attached to both of the vancomycin amino groups | DNPEP, NPEPPS, DDOST | SLC7A5 42/4885TSHR 3911/4885GABRR1 1895/4885 |
| US-20080039436-A1 | Porphyrin Derivatives And Their Use In Photon Activation Therapy | PPOX, PPIF, AIFM1 | SLC7A5 2567/4885TSHR 3745/4885GABRR1 4319/4885 |
| US-20050031575-A1 | Block copolymers | ACSL6, F12, ACSL1 | SLC7A5 257/4885TSHR 1536/4885GABRR1 2266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.